You need to create a user account to read this article.
With a subscription you unlock more content on BioStock.
Sanofi Ventures doubles down on early-stage biotech with $625M boost
Text:
Tommie Anderberg | [email protected]
As venture capital for early-stage biotech companies becomes increasingly limited, Sanofi is choosing to go against the grain. Through its investment arm Sanofi Ventures, the pharmaceutical giant is raising an additional USD 625 million, raising the total...